CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

2D TelemedicineWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (6)

Name (Synonyms) Correlation
drug703 Rivaroxaban 2.5 MG Wiki 1.00
drug206 Clopidogrel 75mg Wiki 1.00
drug71 Atorvastatin 40mg Wiki 1.00
drug65 Aspirin 75mg Wiki 1.00
drug576 Omeprazole 20mg Wiki 1.00
drug18 3D Telemedicine Wiki 1.00

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D054058 Acute Coronary Syndrome NIH 0.71

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 A Comparison of 3D and 2D Telemedicine: Communication During Covid 19

It is critical to establish an effective form of telemedicine during the Covid 19 pandemic, that will allow safe social distancing of clinicians and patients. The investigators serve as the regional plastic, burns and reconstructive centre for the West of Scotland, population 3 million. All face to face clinics have been cancelled and converted to telephone/telemedicine only consultations. The investigators will establish both 2D and 3D telemedicine as normal patient follow up practice during this period. The aim is to implement a 3D telemedicine system to facilitate patient follow up and remote physiotherapy, that will act as if the patient is physically 'present' in the room. Physiotherapy is crucial to patient outcomes after burns contractures, hand trauma and cancer reconstruction. The 3D telemedicine system will be built by an industrial partner, with CE marked equipment, specifically to help during the Covid-19 Pandemic. This study forms a follow on study to the investigator's pilot study (based on clinical feedback only)

NCT04359225 Telehealth Other: 3D Telemedicine Other: 2D Telemedicine

Primary Outcomes

Description: University Hospitals of North Northway questionnaire. Outcome scale with a sum score 1 to 5 Higher score is worse

Measure: University Hospitals of North Northway questionnaire

Time: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient)

Description: Scale 1 to 9 Higher score is worse

Measure: Mental effort rating scale

Time: Single time point at day 1(Clinician assesses telemedicine system once after seeing patient)

Secondary Outcomes

Description: Telehealth Usability Questionnaire. 21 domains, each with scale 1 to 7. Higher is better.

Measure: Telehealth Usability Questionnaire

Time: Single time point at day 1 (Clinician assesses telemedicine system once after seeing patient)

Description: Clinician Subjective feedback. This is an interview performed by a psychologist and will be transcribed, coded and thematically analysed. There is no statistical analysis or outcome scale involved.

Measure: Subjective feedback interview

Time: Once at study completion, an average of 18 months.

No related HPO nodes (Using clinical trials)